101 related articles for article (PubMed ID: 10633487)
1. Instrumentally detected changes in motor functioning in patients with low levels of antipsychotic dopamine D2 blockade.
Fitzgerald PB; Kapur S; Caligiuri MP; Jones C; Silvestri S; Remington G; Zipursky RB
Neuropsychopharmacology; 2000 Jan; 22(1):19-26. PubMed ID: 10633487
[TBL] [Abstract][Full Text] [Related]
2. Dopamine D2 and D3 receptor occupancy in normal humans treated with the antipsychotic drug aripiprazole (OPC 14597): a study using positron emission tomography and [11C]raclopride.
Yokoi F; Gründer G; Biziere K; Stephane M; Dogan AS; Dannals RF; Ravert H; Suri A; Bramer S; Wong DF
Neuropsychopharmacology; 2002 Aug; 27(2):248-59. PubMed ID: 12093598
[TBL] [Abstract][Full Text] [Related]
3. Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia.
Kapur S; Zipursky R; Jones C; Remington G; Houle S
Am J Psychiatry; 2000 Apr; 157(4):514-20. PubMed ID: 10739409
[TBL] [Abstract][Full Text] [Related]
4. Test-retest reliability of central [11C]raclopride binding at high D2 receptor occupancy. A PET study in haloperidol-treated patients.
Nyberg S; Farde L; Halldin C
Psychiatry Res; 1996 Oct; 67(3):163-71. PubMed ID: 8912956
[TBL] [Abstract][Full Text] [Related]
5. Predicting haloperidol occupancy of central dopamine D2 receptors from plasma levels.
Fitzgerald PB; Kapur S; Remington G; Roy P; Zipursky RB
Psychopharmacology (Berl); 2000 Mar; 149(1):1-5. PubMed ID: 10789875
[TBL] [Abstract][Full Text] [Related]
6. PET evidence that loxapine is an equipotent blocker of 5-HT2 and D2 receptors: implications for the therapeutics of schizophrenia.
Kapur S; Zipursky R; Remington G; Jones C; McKay G; Houle S
Am J Psychiatry; 1997 Nov; 154(11):1525-9. PubMed ID: 9356559
[TBL] [Abstract][Full Text] [Related]
7. Striatal D2 dopamine receptor characteristics in neuroleptic-naive schizophrenic patients studied with positron emission tomography.
Hietala J; Syvälahti E; Vuorio K; Någren K; Lehikoinen P; Ruotsalainen U; Räkköläinen V; Lehtinen V; Wegelius U
Arch Gen Psychiatry; 1994 Feb; 51(2):116-23. PubMed ID: 7905257
[TBL] [Abstract][Full Text] [Related]
8. No support for regional selectivity in clozapine-treated patients: a PET study with [(11)C]raclopride and [(11)C]FLB 457.
Talvik M; Nordström AL; Nyberg S; Olsson H; Halldin C; Farde L
Am J Psychiatry; 2001 Jun; 158(6):926-30. PubMed ID: 11384901
[TBL] [Abstract][Full Text] [Related]
9. Delayed normalization of central D2 dopamine receptor availability after discontinuation of haloperidol decanoate. Preliminary findings.
Nyberg S; Farde L; Halldin C
Arch Gen Psychiatry; 1997 Oct; 54(10):953-8. PubMed ID: 9337776
[TBL] [Abstract][Full Text] [Related]
10. Dopamine D2 receptor binding in drug-naïve patients with schizophrenia examined with raclopride-C11 and positron emission tomography.
Talvik M; Nordström AL; Okubo Y; Olsson H; Borg J; Halldin C; Farde L
Psychiatry Res; 2006 Dec; 148(2-3):165-73. PubMed ID: 17095199
[TBL] [Abstract][Full Text] [Related]
11. Prolactin plasma levels and D2-dopamine receptor occupancy measured with IBZM-SPECT.
Schlegel S; Schlösser R; Hiemke C; Nickel O; Bockisch A; Hahn K
Psychopharmacology (Berl); 1996 Apr; 124(3):285-7. PubMed ID: 8740053
[TBL] [Abstract][Full Text] [Related]
12. Extrastriatal and striatal D(2) dopamine receptor blockade with haloperidol or new antipsychotic drugs in patients with schizophrenia.
Xiberas X; Martinot JL; Mallet L; Artiges E; Loc'H C; Mazière B; Paillère-Martinot ML
Br J Psychiatry; 2001 Dec; 179():503-8. PubMed ID: 11731352
[TBL] [Abstract][Full Text] [Related]
13. Increased dopamine d(2) receptor occupancy and elevated prolactin level associated with addition of haloperidol to clozapine.
Kapur S; Roy P; Daskalakis J; Remington G; Zipursky R
Am J Psychiatry; 2001 Feb; 158(2):311-4. PubMed ID: 11156818
[TBL] [Abstract][Full Text] [Related]
14. High levels of dopamine D2 receptor occupancy with low-dose haloperidol treatment: a PET study.
Kapur S; Remington G; Jones C; Wilson A; DaSilva J; Houle S; Zipursky R
Am J Psychiatry; 1996 Jul; 153(7):948-50. PubMed ID: 8659621
[TBL] [Abstract][Full Text] [Related]
15. Suggested minimal effective dose of risperidone based on PET-measured D2 and 5-HT2A receptor occupancy in schizophrenic patients.
Nyberg S; Eriksson B; Oxenstierna G; Halldin C; Farde L
Am J Psychiatry; 1999 Jun; 156(6):869-75. PubMed ID: 10360125
[TBL] [Abstract][Full Text] [Related]
16. D2-receptor upregulation is dependent upon temporal course of D2-occupancy: a longitudinal [11C]-raclopride PET study in cats.
Ginovart N; Wilson AA; Hussey D; Houle S; Kapur S
Neuropsychopharmacology; 2009 Feb; 34(3):662-71. PubMed ID: 18688210
[TBL] [Abstract][Full Text] [Related]
17. Measurement of striatal and thalamic dopamine D2 receptor binding with 11C-raclopride.
Hirvonen J; Aalto S; Lumme V; Någren K; Kajander J; Vilkman H; Hagelberg N; Oikonen V; Hietala J
Nucl Med Commun; 2003 Dec; 24(12):1207-14. PubMed ID: 14627846
[TBL] [Abstract][Full Text] [Related]
18. 5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: a PET investigation.
Kapur S; Zipursky RB; Remington G; Jones C; DaSilva J; Wilson AA; Houle S
Am J Psychiatry; 1998 Jul; 155(7):921-8. PubMed ID: 9659858
[TBL] [Abstract][Full Text] [Related]
19. Dopamine blockade and clinical response: evidence for two biological subgroups of schizophrenia.
Wolkin A; Barouche F; Wolf AP; Rotrosen J; Fowler JS; Shiue CY; Cooper TB; Brodie JD
Am J Psychiatry; 1989 Jul; 146(7):905-8. PubMed ID: 2568094
[TBL] [Abstract][Full Text] [Related]
20. Are animal studies of antipsychotics appropriately dosed? Lessons from the bedside to the bench.
Kapur S; Wadenberg ML; Remington G
Can J Psychiatry; 2000 Apr; 45(3):241-6. PubMed ID: 10779880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
